SPEC — SpectraCure AB (publ) Income Statement
0.000.00%
Last trade - 00:00
- SEK278.77m
- SEK228.53m
- SEK2.84m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.25 | 5.1 | 5.74 | 2.94 | 2.84 |
Cost of Revenue | |||||
Gross Profit | 5.87 | 7.45 | 7.13 | 5.99 | 12.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 16.8 | 20.4 | 29.1 | 28.7 | 24.2 |
Operating Profit | -13.6 | -15.3 | -23.3 | -25.7 | -21.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -13.7 | -15.4 | -23.3 | -25.4 | -20.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.7 | -15.4 | -23.3 | -25.4 | -20.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -13.7 | -15.4 | -23.3 | -25.4 | -20.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.7 | -15.4 | -23.3 | -25.4 | -20.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.165 | -0.167 | -0.24 | -0.261 | -0.21 |
Dividends per Share |